Cancer drug shows promise in limiting COVID-19 inflammation

A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.

Leave A Comment

Your email address will not be published. Required fields are marked *